CTRI/2022/08/045044尚未招募未知
A pharmacogenomics study to identify genetic risk factors for development of Ethambutol optic neuropathy
Duke NUS Program Grant Award0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1)Patients newly started on anti tuberculosis treatment will be included in the study.
- •2)Each patient will be followed up until the duration of treatment is completed depending on the treatment regime.
- •3)Once follow up is completed for all recruited patients, EON(Ethambutol optic neuropathy) will be defined by visual acuity assessment to test the inability of the patient to see clearly in dim light post treatment.
- •4)Patients who develop EON during the study period will be classified as cases and treated patients who did not develop EON will be classified as controls.
排除标准
- •Patients with previous optic neuropathy of other causes and retinal pathology causing vision impairment will be excluded
研究者
相似试验
招募中
不适用
A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patientsgastric cancerJPRN-UMIN000004968Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka100
招募中
不适用
Pharmacogenetic analysis to investigate the association between efficacy and neurotoxicity of oxaliplatin and single nucleotide polymorphismsColorectal cancerJPRN-UMIN000002490Kyoto University Hospital133
招募中
不适用
Associations between (Pharmaco-) genetic Markers and Postoperative Inguinal Pain after Inguinal Hernia RepairDRKS00034796niversität Basel, Departement Pharmazeutische Wissenschaften350
已完成
3 期
Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of strokeIschemic strokeJPRN-UMIN000008055Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences1,000
招募中
不适用
Evaluation of the effect of the genetic polymorphism of drug metabolizing enzyme/transporter and drug interaction on the pharmacokinetics and pharmacodynamics of clopidogrelKCT0000429Seoul National University18